These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain. Totterdell S; Hanger D; Meredith GE Brain Res; 2004 Apr; 1004(1-2):61-72. PubMed ID: 15033420 [TBL] [Abstract][Full Text] [Related]
25. Reduced expression of the presynaptic co-chaperone cysteine string protein alpha (CSPα) does not exacerbate experimentally-induced ME7 prion disease. Davies MJ; Cooper M; Perry VH; O'Connor V Neurosci Lett; 2015 Mar; 589():138-43. PubMed ID: 25623034 [TBL] [Abstract][Full Text] [Related]
26. Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Kontopoulos E; Parvin JD; Feany MB Hum Mol Genet; 2006 Oct; 15(20):3012-23. PubMed ID: 16959795 [TBL] [Abstract][Full Text] [Related]
27. Functional protein kinase arrays reveal inhibition of p-21-activated kinase 4 by alpha-synuclein oligomers. Danzer KM; Schnack C; Sutcliffe A; Hengerer B; Gillardon F J Neurochem; 2007 Dec; 103(6):2401-7. PubMed ID: 17883396 [TBL] [Abstract][Full Text] [Related]
28. Chaperoning the SNAREs: a role in preventing neurodegeneration? Burgoyne RD; Morgan A Nat Cell Biol; 2011 Jan; 13(1):8-9. PubMed ID: 21173802 [TBL] [Abstract][Full Text] [Related]
29. A charged prominence in the linker domain of the cysteine-string protein Cspα mediates its regulated interaction with the calcium sensor synaptotagmin 9 during exocytosis. Boal F; Laguerre M; Milochau A; Lang J; Scotti PA FASEB J; 2011 Jan; 25(1):132-43. PubMed ID: 20847230 [TBL] [Abstract][Full Text] [Related]
30. Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression. Fan Y; Limprasert P; Murray IV; Smith AC; Lee VM; Trojanowski JQ; Sopher BL; La Spada AR Hum Mol Genet; 2006 Oct; 15(20):3002-11. PubMed ID: 16959793 [TBL] [Abstract][Full Text] [Related]
31. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins. Schnack C; Danzer KM; Hengerer B; Gillardon F Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383 [TBL] [Abstract][Full Text] [Related]
32. Identification of CSPα clients reveals a role in dynamin 1 regulation. Zhang YQ; Henderson MX; Colangelo CM; Ginsberg SD; Bruce C; Wu T; Chandra SS Neuron; 2012 Apr; 74(1):136-50. PubMed ID: 22500636 [TBL] [Abstract][Full Text] [Related]
33. Alpha-synuclein deficiency affects brain Foxp1 expression and ultrasonic vocalization. Kurz A; Wöhr M; Walter M; Bonin M; Auburger G; Gispert S; Schwarting RK Neuroscience; 2010 Mar; 166(3):785-95. PubMed ID: 20056137 [TBL] [Abstract][Full Text] [Related]
34. Expression of alpha-synuclein in different brain parts of adult and aged rats. Adamczyk A; Solecka J; Strosznajder JB J Physiol Pharmacol; 2005 Mar; 56(1):29-37. PubMed ID: 15795473 [TBL] [Abstract][Full Text] [Related]
35. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD. Miller RM; Kiser GL; Kaysser-Kranich T; Casaceli C; Colla E; Lee MK; Palaniappan C; Federoff HJ Exp Neurol; 2007 Mar; 204(1):421-32. PubMed ID: 17254569 [TBL] [Abstract][Full Text] [Related]
36. Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein. Park SS; Schulz EM; Lee D Eur J Neurosci; 2007 Dec; 26(11):3104-12. PubMed ID: 18005066 [TBL] [Abstract][Full Text] [Related]
37. Microarray expression analysis of human dopaminergic neuroblastoma cells after RNA interference of SNCA--a key player in the pathogenesis of Parkinson's disease. Häbig K; Walter M; Stappert H; Riess O; Bonin M Brain Res; 2009 Feb; 1256():19-33. PubMed ID: 19135032 [TBL] [Abstract][Full Text] [Related]
38. Identification of the amino acid sequence motif of alpha-synuclein responsible for macrophage activation. Lee SB; Park SM; Ahn KJ; Chung KC; Paik SR; Kim J Biochem Biophys Res Commun; 2009 Mar; 381(1):39-43. PubMed ID: 19351591 [TBL] [Abstract][Full Text] [Related]
39. L116 Deletion in CSPα Promotes α-Synuclein Aggregation and Neurodegeneration. Guo T; Xiong J; Feng H; Bu L; Xiao T; Zhou L; He J; Deng M; Liu Y; Zhang Z; Zhang Z Mol Neurobiol; 2024 Jan; 61(1):15-27. PubMed ID: 37566176 [TBL] [Abstract][Full Text] [Related]
40. Evidence that the presynaptic vesicle protein CSPalpha is a key player in synaptic degeneration and protection in Alzheimer's disease. Tiwari SS; d'Orange M; Troakes C; Shurovi BN; Engmann O; Noble W; Hortobágyi T; Giese KP Mol Brain; 2015 Jan; 8():6. PubMed ID: 25631211 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]